Skip to main content
. 2023 Jun 22;13(7):e2931. doi: 10.1002/brb3.2931

TABLE 1.

Descriptive statics of ALS patients and healthy controls; data are shown as mean (standard deviation) or count (percentage)

Variable ALS (n = 130) HC (n = 27) F test/χ2 p Value
Demographics
Age, years 60.39 (9.38) 58.48 (12.07) 0.83 .362
Education, years 10.52 (4.47) 10.63 (3.87) 0.01 .909
Sex, male 80 (61.50%) 21 (77.80%) 2.56 .109
Clinical and motor features
Disease Duration, months 27.19 (31.35)
ALSFRS‐R total score 37.09 (6.98)
ALSFRS‐R subscores
Bulbar 10.54 (1.96)
Fine motor 8.12 (3.23)
Gross motor 7.30 (3.19)
Respiratory 11.10 (1.78)
Upper motor neuron score 8.31 (4.28)
Patients under NIV 10 (7.69%)
Patients with PEG 3 (2.30%)
Patients using Riluzole 119 (91.53%)
Extra‐motor features
ECAS total score 86.45 (22.88)
ECAS subscores
Executive functions 26.54 (9.98)
Fluency 15.68 (6.68)
Language 20.73 (5.06)
Memory 12.75 (5.21)
Visuospatial abilities 10.69 (1.49)
Beck Depression Inventory‐II 9.63 (8.37)
STAI form Y‐1 37.49 (11.50)
DAS total score 19.70 (9.20)
DAS subscales
Executive 3.64 (3.86)
Emotional 6.78 (3.81)
Cognitive and behavioral initiation 9.33 (5.60)
Epworth Sleepiness Scale 4.60 (3.22)
Fatigue measures
MFI total score 58.92 (17.36)
MFI subscales
Physical fatigue 15.17 (4.21)
Mental fatigue 7.45 (4.42)
General fatigue 13.45 (4.53)
Reduced activity 12.42 (5.02)
Reduced motivation 10.42 (4.13)

ALS, amyotrophic lateral sclerosis; HC, healthy controls; ALSFRS‐R, ALS Functional Rating Scale—Revised; NIV, noninvasive ventilation; PEG, percutaneous endoscopic gastrostomy; ECAS, Edinburgh Cognitive and Behavioral ALS Screen; DAS, Dimensional Apathy Scale; STAI, State‐Trait Anxiety Inventory; MFI, Multidimensional Fatigue Inventory.